 |
|
Researchers identify new leprosy bacterium
November 25, 2008HOUSTON - A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology.
All cases of leprosy, an ancient disease that still maims and kills in the developing world, previously had been thought to be caused by a single species of bacterium, said lead author Xiang-Yang Han, M.D., Ph.D., associate professor in Laboratory Medicine at The University of Texas M. D. Anderson Cancer Center.
"We have identified a second species of leprosy mycobacterium, and in identifying this killing organism we've better defined the disease that it causes, diffuse lepromatous leprosy (DLL)." Han said. DLL occurs mainly in Mexico and the Caribbean.
There are hundreds of thousands of new cases of leprosy worldwide each year, but the disease is rare in the United States, with 100-200 new cases annually, mostly among immigrants. Leprosy initially attacks skin and nerve cells. It can be successfully treated with antibiotics in its early and intermediate stages.
R. Geetha Nair, M.D., a physician with Maricopa Integrated Health System in Phoenix, contacted Han in 2007 for help confirming a possible leprosy diagnosis in a patient who died that February.
The patient, a 53-year-old man originally from Mexico, was admitted that month for treatment of extensive leg wounds. While undergoing antibiotic treatment and additional diagnostic testing the next day, he was stricken with high fever and shock. He died after 10 days in intensive care.
Analysis of autopsied tissue at the Phoenix hospital suggested a diagnosis of diffuse lepromatous leprosy, a form first described in Mexico in 1852. Han said DLL uniquely attacks a patient's skin vasculature, blocking or impeding blood flow. This leads to extensive skin death at late stage and may cause secondary infection and fatal shock. The DLL bacterium had never been studied.
The research team also analyzed samples from a similar lethal case of a 31-year-old man in 2002 with so much skin damage that he was first admitted to a hospital burn unit.
Telltale fingerprint points to new species
Han and M. D. Anderson colleagues diagnose infections in cancer patients. Han developed in 2002 a way to identify unusual bacteria by analyzing small but significant differences in the 16S ribosomal RNA gene. "This is like a fingerprint analysis to solve crimes," Han said. He has discovered and named several new bacterial species that cause unusual infections.
Across a group of bacteria called mycobacteria, the 16S rRNA gene is 93 to 100 percent identical. There are 110 species of mycobacteria, with those causing tuberculosis and leprosy the best known. Sequencing the 16S rRNA gene is a fast and accurate way to identify mycobacteria, which usually grow slowly, Han noted. Accurate identification improves patient care decisions.
Han and colleagues compared the lethal bacterium's 16S rRNA gene and five other genes to other mycobacteria. They found that the bacterium had the most in common with Mycobacterium leprae, previously thought to be the sole cause of leprosy.
Yet there were also significant differences with M. leprae. The lethal bacterium's 16S rRNA gene sequence differed by 2.1 percent. "That may sound like a small difference, but to anyone familiar with mycobacteria, it's huge," Han said. In all previously studied M. leprae strains, no variation in the 16S rRNA gene had been noted at all.
Analysis of the other five genes turned up more differences. The researchers named the new species Mycobacterium lepromatosis. They have since confirmed M. lepromatosis as the cause of two lethal cases of DLL in Singapore.
What's next for M. lepromatosis
The team is working to better understand the bacterium and how it causes DLL. They are attempting to sequence the entire M. lepromatosis genome and looking for ways to grow the organism in the lab. Neither leprosy mycobacteria can be cultured because over millions of years they lost genes necessary to survive outside their hosts, a process called reductive evolution.
One of the puzzles of leprosy is that M leprae strains collected worldwide are virtually identical, while the clinical features of the disease and its severity vary greatly both geographically and from person to person. Evidence suggests that individual host immune factors play the key role in determining how the disease progresses.
The authors conclude that the new species M lepromatosis could account for some of this geographical and individual variation.
University of Texas M. D. Anderson Cancer Center
There are hundreds of thousands of new cases of leprosy worldwide each year, but the disease is rare in the United States, with 100-200 new cases annually, mostly among immigrants. Leprosy initially attacks skin and nerve cells. It can be successfully treated with antibiotics in its early and intermediate stages.
R. Geetha Nair, M.D., a physician with Maricopa Integrated Health System in Phoenix, contacted Han in 2007 for help confirming a possible leprosy diagnosis in a patient who died that February.
The patient, a 53-year-old man originally from Mexico, was admitted that month for treatment of extensive leg wounds. While undergoing antibiotic treatment and additional diagnostic testing the next day, he was stricken with high fever and shock. He died after 10 days in intensive care.
Analysis of autopsied tissue at the Phoenix hospital suggested a diagnosis of diffuse lepromatous leprosy, a form first described in Mexico in 1852. Han said DLL uniquely attacks a patient's skin vasculature, blocking or impeding blood flow. This leads to extensive skin death at late stage and may cause secondary infection and fatal shock. The DLL bacterium had never been studied.
The research team also analyzed samples from a similar lethal case of a 31-year-old man in 2002 with so much skin damage that he was first admitted to a hospital burn unit.
Telltale fingerprint points to new species
Han and M. D. Anderson colleagues diagnose infections in cancer patients. Han developed in 2002 a way to identify unusual bacteria by analyzing small but significant differences in the 16S ribosomal RNA gene. "This is like a fingerprint analysis to solve crimes," Han said. He has discovered and named several new bacterial species that cause unusual infections.
Across a group of bacteria called mycobacteria, the 16S rRNA gene is 93 to 100 percent identical. There are 110 species of mycobacteria, with those causing tuberculosis and leprosy the best known. Sequencing the 16S rRNA gene is a fast and accurate way to identify mycobacteria, which usually grow slowly, Han noted. Accurate identification improves patient care decisions.
Han and colleagues compared the lethal bacterium's 16S rRNA gene and five other genes to other mycobacteria. They found that the bacterium had the most in common with Mycobacterium leprae, previously thought to be the sole cause of leprosy.
Yet there were also significant differences with M. leprae. The lethal bacterium's 16S rRNA gene sequence differed by 2.1 percent. "That may sound like a small difference, but to anyone familiar with mycobacteria, it's huge," Han said. In all previously studied M. leprae strains, no variation in the 16S rRNA gene had been noted at all.
Analysis of the other five genes turned up more differences. The researchers named the new species Mycobacterium lepromatosis. They have since confirmed M. lepromatosis as the cause of two lethal cases of DLL in Singapore.
What's next for M. lepromatosis
The team is working to better understand the bacterium and how it causes DLL. They are attempting to sequence the entire M. lepromatosis genome and looking for ways to grow the organism in the lab. Neither leprosy mycobacteria can be cultured because over millions of years they lost genes necessary to survive outside their hosts, a process called reductive evolution.
One of the puzzles of leprosy is that M leprae strains collected worldwide are virtually identical, while the clinical features of the disease and its severity vary greatly both geographically and from person to person. Evidence suggests that individual host immune factors play the key role in determining how the disease progresses.
The authors conclude that the new species M lepromatosis could account for some of this geographical and individual variation.
University of Texas M. D. Anderson Cancer Center
Leprosy Current Events and Leprosy News RSSUAB Researchers Find TB-Prevention Therapy Is Cost-Effective Option
University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency virus (HIV) is generally less expensive than the reported cost of treating newly confirmed TB cases.
Unexpected discovery can open a new chapter in the fight against tuberculosis
A close relative of the microorganism that causes tuberculosis in humans has been found to form spores.
Oldest evidence of leprosy found in India
A biological anthropologist from Appalachian State University working with an undergraduate student from Appalachian, an evolutionary biologist from UNC Greensboro, and a team of archaeologists from Deccan College (Pune, India) recently reported analysis of a 4000-year-old skeleton from India bearing evidence of leprosy.
How much is the world spending on neglected disease research and development?
The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total.
Forgotten, but not gone: Leprosy still present in the US
Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States. "Approximately 150 cases are diagnosed each year with 3,000 people in the U.S. currently being treated for leprosy.
Blood pressure enzyme can have tumor-sensing role
By increasing production of a blood pressure-regulating enzyme in mice, researchers have found they can enhance the mouse immune system's ability to sense tumor growth.
Study finds multiple neglected tropical diseases effectively treated with drugs
The neglected tropical diseases are a group of 13 infectious diseases, including elephantiasis, hookworm, African sleeping sickness and trachoma, which affect more than 1 billion people worldwide, most of whom live in extreme poverty.
Drugstore in the Dirt
French clay that kills several kinds of disease-causing bacteria is at the forefront of new research into age-old, nearly forgotten, but surprisingly potent cures.
The 'MIP-MAP' game: Indian bug is the ancestor of Crohn's disease pathogen
An Indian team of researchers led by Seyed E. Hasnain of the Institute of Life Sciences (ILS), University of Hyderabad, India has found that a seemingly unknown mycobacterial organism Mycobacterium indicus pranii (MIP) could be the earliest ancestor of the 'generalist' branch of mycobacterial pathogens.
ASU researchers test antibacterial effects of healing clays
Clay is most commonly associated with the sublime experience of the European spa where visitors have been masked, soaked and basted with this touted curative since the Romans ruled.
More Leprosy Current Events and Leprosy News Articles
 |
Squint: My Journey with Leprosy (Willie Morris Books in Memoir and Biography) by Jose P. Ramirez Jr. (Author), James Carville (Foreword) Lying in a hospital bed, José P. Ramirez, Jr. (b. 1948) almost lost everything because of a misunderstood disease. When the health department doctor gave him the Handbook for Persons with Leprosy, Ramirez learned his fate. Such a diagnosis in 1968 meant exile and hospitalization in the only leprosarium in the continental United States--Carville, Louisiana, 750 miles from his home in Laredo, Texas. In Squint: My Journey with Leprosy, Ramirez recalls being taken from his family in a hearse and thrown into a world filled with fear. He and his loved ones struggled against the stigma associated with the term "leper" and against beliefs that the disease was a punishment from God, that his illness was highly communicable, and that persons with Hansen's disease had to be banished from their... |
 |
The Colony: The Harrowing True Story of the Exiles of Molokai by John Tayman (Author) Beginning in 1866 and continuing for over a century, more than eight thousand people suspected of having leprosy were forcibly exiled to the Hawaiian island of Molokai -- the longest and deadliest instance of medical segregation in American history. Torn from their homes and families, these men, women, and children were loaded into shipboard cattle stalls and abandoned in a lawless place where brutality held sway. Many did not have leprosy, and many who did were not contagious, yet all were ensnared in a shared nightmare. Here, for the first time, John Tayman reveals the complete history of the Molokai settlement and its unforgettable inhabitants. It's an epic of ruthless manhunts, thrilling escapes, bizarre medical experiments, and tragic, irreversible error. Carefully researched and... |
 |
Carville: Remembering Leprosy in America by Marcia Gaudet (Author), James Carville (Foreword) Mysterious and misunderstood, distorted by biblical imagery of disfigurement and uncleanness, Hansen's disease (or leprosy) has all but disappeared from America's consciousness. In Carville, Louisiana, the closed doors of the nation's last center for the treatment of leprosy hold stories of sadness, separation, and even strength in the face of what was once a life-wrenching diagnosis. Drawn from interviews with living patients and extensive research in the leprosarium's archives, "Carville: Remembering Leprosy in America" tells the stories of former patients at the National Hansen's Disease Center. For over a century, from 1894 until 1999, Carville was the site of the only in-patient hospital in the continental United States for the treatment of Hansen's disease, which is the... |
 |
No Footprints in the Sand - A Memoir of Kalaupapa by Henry Kalalahilimoku Nalaielua (Author), Sally-Jo Keala-o-anuenue Bowman (Author) |
|
Disease Apart: Leprosy in the Modern World by Tony Gould (Author) This fascinating cultural and medical history of leprosy enriches our understanding of a still-feared biblical disease. It is a condition shrouded for centuries in mystery, legend, and religious fanaticism. Societies the world over have vilified its sufferers: by the sheer accident of mycobacterial infection, they have been condemned to exile and imprisonment—illness itself considered evidence of moral taint. Over the last 200 years, the story of leprosy has witnessed dramatic reversals in terms of both scientific theory and public opinion. In A DISEASE APART, Tony Gould traces the history of this compelling period through the lives of individual men and women: intrepid doctors, researchers, and missionaries, and a vast spectrum of patients. We meet such pioneers of... | |
 |
Moloka'i by Alan Brennert (Author) This richly imagined novel, set in Hawaii more than a century ago, is an extraordinary epic of a little-known time and place---and a deeply moving testament to the resiliency of the human spirit. Rachel Kalama, a spirited seven-year-old Hawaiian girl, dreams of visiting far-off lands like her father, a merchant seaman. Then one day a rose-colored mark appears on her skin, and those dreams are stolen from her. Taken from her home and family, Rachel is sent to Kalaupapa, the quarantined leprosy settlement on the island of Moloka'i. Here her life is supposed to end---but instead she discovers it is only just beginning. With a vibrant cast of vividly realized characters, Moloka'i is the true-to-life chronicle of a people who embraced life in the face of death. Such is... |
 |
Leprosy in Premodern Medicine: A Malady of the Whole Body by Luke Demaitre (Author) While premodern poets and preachers viewed leprosy as a "disease of the soul," physicians in the period understood it to be a "cancer of the whole body." In this innovative study, medical historian Luke Demaitre explores medical and social perspectives on leprosy at a time when judicious diagnosis could spare healthy people from social ostracization and help the afflicted get a license to beg. Extending his inquiry from the first century to late in the eighteenth century, Demaitre draws on translations of academic treatises and archival records to illuminate the professional standing, knowledge, and conduct of the practitioners who struggled to move popular perceptions of leprosy beyond loathing and pity. He finds that, while not immune to social and cultural perceptions of the... |
 |
The Pearl Diver by Jeff Talarigo (Author) In 1948, a nineteen-year-old pearl diver's dreams of spending her life combing the waters of Japan’s Inland Sea are shattered when she discovers she has leprosy. By law, she is exiled to an island leprosarium, where she is stripped of her dignity and instructed to forget her past. Her name is erased from her family records, and she is forced to select a new one. To the two thousand patients on the island of Nagashima, she becomes Miss Fuji. Although drugs arrest the course of Miss Fuji's disease, she cannot leave the colony. Instead, she becomes a caretaker to the other patients, and through the example of their courage, she gains insight into the deep wellspring of strength she will need to reclaim her freedom. Written with precision and eloquence, The Pearl Diver is a dazzling... |
 |
In the Sanctuary of Outcasts: A Memoir by Neil White (Author) Daddy is going to camp. That’s what I told my children. A child psychologist suggested it. “Words like prison and jail conjure up dangerous images for children,” she explained. But it wasn’t camp . . . Neil White, a journalist and magazine publisher, wanted the best for those he loved—nice cars, beautiful homes, luxurious clothes. He loaned money to family and friends, gave generously to his church, and invested in his community—but his bank account couldn’t keep up. Soon White began moving money from one account to another to avoid bouncing checks. His world fell apart when the FBI discovered his scheme and a judge sentenced him to serve eighteen months in a federal prison. But it was no ordinary prison. The beautiful, isolated colony in Carville,... |
 |
Leprosy (Deadly Diseases and Epidemics) by Alfica Sehgal (Author) Leprosy, a bacterial disease that usually afflicts the skin, nerves, respiratory tract, and eyes, has plagued humanity since history was recorded. |
| © 2009 BrightSurf.com |